Europska Unija - hrvatski - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Europska Unija - hrvatski - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - multipla skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

medis international d.o.o. sarajevo - natalizumab - koncentrat za rastvor za infuziju - 300 mg/15 ml - 1 bočica sa 15 ml koncetrata za rastvor za infuziju sadrži: 300 mg natalizumaba

Crna Gora - hrvatski - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - natalizumab - rastvor za injekciju u napunjenom injekcionom špricu - 150mg

Crna Gora - hrvatski - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - natalizumab - koncentrat za rastvor za infuziju - 300mg/15ml

Europska Unija - hrvatski - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

proton med d.o.o. banja luka - финголимод - kapsula, tvrda - 0,56 mg/1 kapsula - 1 kapsula, tvrda sadrži: 0,5 mg fingolimoda (u obliku 0,56 mg fingolimod hidrohlorida)

Crna Gora - hrvatski - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"farmont m.p." d.o.o. za proizvodnju, promet i usluge, export-import danilovgrad - fingolimod - kapsula, tvrda - 0.5mg

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

medochemie ltd., constatinoupoleos str. 1-10, limassol, cipar - fingolimodklorid - kapsula, tvrda - 0,5 mg - urbroj: svaka kapsula sadrži 0,5 mg fingolimoda (u obliku fingolimodklorida)

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

stada d.o.o., hercegovačka 14, zagreb, hrvatska - fingolimodklorid - kapsula, tvrda - 0,5 mg - urbroj: jedna kapsula sadrži 0,5 mg fingolimoda (u obliku fingolimodklorida)